Full-Time
Confirmed live in the last 24 hours
Non-invasive cardiac testing for heart disease
$100k - $140kAnnually
Senior
Austin, TX, USA
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main products include the HeartFlow Analysis, which encompasses various analyses like FFRCT, RoadMap, Plaque, and HeartFlow Planner. These products have received FDA clearance and are available in the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a safer and more efficient diagnostic method for cardiovascular care. The company's goal is to enhance the quality of heart disease treatment through its proprietary technology, ultimately improving patient outcomes.
Company Stage
Series F
Total Funding
$858.5M
Headquarters
Redwood City, California
Founded
2010
Help us improve and share your feedback! Did you find this helpful?